Therefore, we treated the HT29 colon cancer cell line, which harbors a missense mutation at codon 273 in the TP53 gene (resulting in a histidine-to-arginine substitution) and is known to overexpress p53, with NaB, and subsequently assessed cell viability. This evidence concerns the gene TP53 and colonic neoplasm.